YOLFTbeta
61

Singbao International Co Ltd

6130 · TWO · Healthcare / Drug Manufacturers - General

23.70TWD+0.60 (+2.60%)

Price History

Full chart

Market Stats

Previous Close23.10
Open23.70
Day Range23.15 – 24.25
52-Week Range20.70 – 48.30
Volume144.25K
Market Cap1.16B
P/E (TTM)0.00
Forward P/E0.00
EPS-1.03
Dividend Yield0.00%
Beta0.27
50-Day Avg25.35
200-Day Avg29.71

About

Shangya Technology Co., Ltd. engages in the generic drugs and solar power generation businesses in Taiwan and Asia. The company wholesales Chinese and Western medicines, medical equipment, and beauty and hair care products; and onrito, lixin fumitation, lufuxing film-coated, amperex film coating, leverb-coated, triton film-coated, special core stabilized, tanlipo film-coated, inhibitory film-coated, yoyo flat mouth dissolved, and binlishu film-coated tablet, as well as pain relief capsules and yue shi tong injection. It is also involved in the research, development, production, and sale of wireless communication integrated circuits, satellite positioning system integrated circuits, and portable product ICs. The company was formerly known as Singbao International Co. Ltd and changed its name to Shangya Technology Co., Ltd. in July 2023. Shangya Technology Co., Ltd. was founded in 1994 and is based in Taipei, Taiwan.

Company Details

  • SectorHealthcare
  • IndustryDrug Manufacturers - General
  • CEOMr. Qian Kui Huang
  • Employees0
  • HeadquartersNo. 188, Nanjing East Road, Taipei, Taiwan, 105052, Taiwan
  • Websitehttps://www.singbao.com

Leadership

  • Mr. Qian Kui HuangChairman & GM
  • Xiao Ling HuangCFO & Accounting Supervisor

Financials

Income Statement

Currency: TWD2015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Revenue244.93M178.58M85.77M53.72M63.47M137.87M103.81M85.17M231.12M195.35M154.74M
Growth (%)--27.09%-51.97%-37.37%+18.16%+117.21%-24.70%-17.96%+171.36%-15.47%-20.79%
Cost of Revenue171.87M130.29M73.00M47.19M39.86M47.91M57.15M50.99M169.94M126.15M108.28M
Gross Profit73.06M48.29M12.77M6.53M23.61M89.95M46.66M34.18M61.17M69.20M46.45M
Gross Margin29.83%27.04%14.89%12.15%37.20%65.25%44.95%40.13%26.47%35.42%30.02%
Operating Expense70.82M44.58M26.07M33.21M39.42M108.57M62.79M57.99M68.92M104.66M120.35M
Operating Income2.24M3.71M-13.30M-26.68M-15.81M-18.62M-16.13M-23.81M-7.74M-35.45M-73.89M
Operating Margin0.91%2.08%-15.50%-49.67%-24.91%-13.50%-15.54%-27.96%-3.35%-18.15%-47.76%
EBITDA-14.13M-4.64M-16.35M-4.93M961.00K515.00K-6.08M22.92M5.87M-49.21M
EBITDA Margin-7.91%-5.41%-30.44%-7.77%0.70%0.50%-7.14%9.92%3.00%-31.80%
Net Income-3.48M2.23M-10.31M-23.45M-16.43M-26.88M32.47M1.28M-80.04M-33.43M-76.31M
Net Income Margin-1.42%1.25%-12.02%-43.66%-25.89%-19.50%31.27%1.50%-34.63%-17.11%-49.32%
R&D--------08.02M24.33M
R&D as % of Total Revenue--------0.00%4.11%15.72%
Interest Expense03.00K681.00K2.14M2.69M9.49M8.34M2.15M3.24M3.07M4.22M
Interest Expense % of Total Revenue0.00%0.00%0.79%3.98%4.24%6.88%8.03%2.53%1.40%1.57%2.73%

Balance Sheet

Currency: TWD2015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Assets335.07M314.67M442.18M412.31M562.21M1.22B550.64M938.96M966.90M978.41M877.78M
Total Liabilities29.47M17.16M158.24M152.61M233.65M788.89M77.98M168.20M166.47M232.17M227.03M
Total Equity295.59M294.68M283.94M259.70M254.85M282.31M472.66M770.76M682.94M624.94M545.47M
Cash143.11M172.06M144.64M70.46M36.15M88.94M44.87M367.56M246.75M241.56M187.59M
Total Debt-378.00K140.11M140.03M207.94M765.81M67.93M146.82M133.03M--
Net Debt--171.68M-4.53M69.56M171.80M676.87M23.06M-220.74M-113.73M--

Cash Flow

Currency: TWD2002-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Operating Cash Flow-23.05M26.52M6.60M-55.29M9.67M21.88M2.50M-17.30M269.00K11.28M-44.15M
Investing Cash Flow--47.23M12.48M-172.67M-10.78M-163.01M-618.60M140.07M----
Financing Cash Flow--53.40M-1.21M142.23M-81.00K65.48M588.20M-35.64M276.91M-23.37M--
Capital Expenditure0476.00K271.00K14.21M35.44M89.62M127.93M0010.95M10.83M75.93M
Free Cash Flow--26.25M-7.61M-90.73M-79.96M-106.05M2.50M-17.30M-10.68M454.00K-120.08M
Dividends Paid-53.40M--------22.15M-
FCF to OCF--98.98%-115.29%164.09%-827.20%-484.64%100.00%100.00%-3969.89%4.02%271.97%
Dividend Paid to FCF----------4878.85%-

Earnings

Report DateMay 12, 2008Feb 19, 2009
EPS Estimate--
EPS Actual-2.79-3.56
Surprise--
TimingPre-marketPre-market

Key Statistics & Ratios

Market Cap1.16B
Enterprise Value1.19B
Trailing P/E0.00
Forward P/E0.00
Price / Sales7.04
Price / Book1.98
EPS-1.03
Book Value12.72
Revenue (TTM)165.30M
Gross Profit (TTM)57.66M
EBITDA-25.24M
Profit Margin-27.61%
Operating Margin5.52%
Return on Equity-8.54%
Return on Assets-3.99%
Shares Outstanding49.30M
Shares Float23.97M
Beta0.27
Dividend Yield0.00%
Dividend Rate0.00
Payout Ratio0.00%

Dividends

20241×
0.50Jul 11, 2024
20151×
1.90Jul 23, 2015
20141×
0.95Jul 31, 2014
20131×
3.08Jul 22, 2013